自7月29日以来公司已连续3日进行回购，合计回购532.40万股，累计回购金额4913.35万港元。 其间该 股累计下跌1.40%。 今年以来该股累计进行29次回购，合计回购2138.00万股，累计回购金额2.00亿港元。（数据宝） | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.07.31 | 200.00 | 9.240 | 9.170 | 1840.78 | | 2025.07.30 | 212.20 | 9.260 | 9.200 | 1959.97 | | 2025.07.29 | 120.20 | 9.260 | 9.240 | 1112.61 | | 2025.07.23 | 140.20 | 9.260 | 9.230 | 1297.92 | | 2025.07.22 | 2.40 | 9.260 | 9.260 | 22.22 | | 2025.07.21 | 5.60 | 9.260 | 9.260 | 51.86 | | 2025.07.18 | 10 ...

Performance Updates - 开拓药业-B (09939.HK) has completed patient enrollment for the Phase III clinical trial of KX-826 solution for androgenetic alopecia in adult males in China [2] - 李氏大药厂 (00950.HK) has received approval from the National Medical Products Administration for Socazolimab to be used in combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer in mainland China [2] - 恒瑞医药 (01276.HK) has received approval for clinical trials of SHR-8068 injection, Adebali monoclonal antibody injection, and Bevacizumab injection [2] - 恒瑞医药 (01276.HK) has also received approval to conduct clinical trials for HRS-5041, intended for prostate cancer treatment [2] - 深圳高速公路股份 (00548.HK) reported toll revenue of 106 million yuan for the outer ring project in June [2] - 大成生化科技 (00809.HK) has signed an EPC contract with Northeast Electric and Liaoning Electric for boiler renovation projects, with a maximum cost of 129.1 million yuan [2] - 小黄鸭德盈 (02250.HK) has signed a contract to develop an AI marketing system to diversify revenue sources [2] Buyback and Financing Activities - 威海银行 (09677.HK) plans to issue up to approximately 758 million domestic shares and 154 million H-shares, raising nearly 3 billion yuan [2] Financial Results - 香港电讯-SS (06823.HK) reported total revenue of 17.322 billion HKD for the first half, a year-on-year increase of 4%, with a net profit of 2.07 billion HKD, also up 4% [4] - 青岛银行 (03866.HK) reported operating revenue of 7.662 billion yuan for the first half, a growth of 7.5%, and a net profit of 3.065 billion yuan, up 16.05% [4] - 中国石油化工股份 (00386.HK) expects mid-term net profit to be between 20.1 billion and 21.6 billion yuan, a year-on-year decline of 39.5%-43.7% [4] - 汽车之家-S (02518.HK) reported total revenue of 3.212 billion yuan for the first half, a decrease of 7.75%, with a net profit of 772 million yuan, down 15.99% [4] - 绿茶集团 (06831.HK) issued a profit warning, expecting mid-term net profit to be between 230 million and 237 million yuan, a year-on-year increase of approximately 32%-36% [4] - 粤海置地 (00124.HK) issued a profit warning, expecting mid-term net profit to exceed 260 million HKD, turning from loss to profit [4] - 药师帮 (09885.HK) issued a profit warning, expecting mid-term net profit to exceed 70 million yuan [4] - 中国东方教育 (00667.HK) issued a profit warning, expecting mid-term net profit to grow by 45%-50% year-on-year [4] - 中核国际 (02302.HK) issued a profit warning, expecting mid-term revenue to increase to at least 585 million HKD, with net profit of at least 9.5 million HKD [4] - 大唐环境 (01272.HK) issued a profit warning, expecting mid-term net profit to decrease to between 350 million and 400 million yuan [4] - 长江生命科技 (00775.HK) issued a profit warning, expecting mid-term net loss of approximately 150 million HKD, turning from profit to loss year-on-year [4] - 延长石油国际 (00346.HK) issued a profit warning, expecting mid-term loss of approximately 27.9 million HKD [4]

智通财经7月31日电，维他奶国际(00345.HK)在港交所发布公告称，当日在香港斥资约1840.8万港元回 购200万股，每股回购价在9.17至9.24港元。 维他奶国际：以约1841万港元回购200万股 ...

智通财经APP讯，VITASOY INT'L(00345)公布，2025年7月31日耗资1840.78万港元回购200万股股份。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 維他奶國際集團有限公司 呈交日期： 2025年7月31日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00345 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | | | | 每股發行/出售價 (註4) | 已發行股份總數 | | | | 已發 ...

证券时报·数据宝统计显示，7月30日有6家香港上市公司进行了股份回购，合计回购963.66万股，回购金 额3542.49万港元。 VITASOY INT'L回购数量212.20万股，回购金额1959.97万港元，回购最高价为9.260港元，最低价为 9.200港元，年内累计回购金额1.82亿港元；中国东方航空股份回购数量250.00万股，回购金额725.36万 港元，回购最高价为2.920港元，最低价为2.890港元，年内累计回购金额6.28亿港元；首程控股回购数 量300.00万股，回购金额562.83万港元，回购最高价为1.880港元，最低价为1.860港元，年内累计回购金 额7289.25万港元。 以金额进行统计，7月30日回购金额最多的是VITASOY INT'L，回购金额为1959.97万港元；其次是中国 东方航空股份，回购金额为725.36万港元；回购金额居前的还有首程控股、捷利交易宝等。回购数量上 看，7月30日回购股数最多的是首程控股，当日回购量为300.00万股；其次是中国东方航空股份、 VITASOY INT'L等，回购数量分别为250.00万股、212.20万股。 值得关注的是，本次回购 ...

Summary of Key Points Core Viewpoint - Several companies, including VITASOY INT'L, Miniso, and China Eastern Airlines, conducted share buybacks on July 30, 2025, with VITASOY INT'L leading in both quantity and monetary value of the buyback [1]. Group 1: Buyback Details - VITASOY INT'L (00345) repurchased 2.122 million shares for a total amount of 19.5997 million yuan, representing 1.806% of its total share capital for the year [2]. - China Eastern Airlines (00670) repurchased 2.5 million shares for 7.2536 million yuan, accounting for 2.202% of its total share capital for the year [2]. - First Travel Holdings (00697) repurchased 3 million shares for 5.6283 million yuan, which is 0.546% of its total share capital for the year [2]. - Jieli Trading (08017) repurchased 2 million shares for 2.689 million yuan, representing 7.480% of its total share capital for the year [2]. - Miniso (09896) repurchased 6.6 million shares for 250,600 yuan, which is 0.268% of its total share capital for the year [2]. - Meiheng Industrial (01897) repurchased 8 million shares for 36 million yuan, accounting for 0.850% of its total share capital for the year [2].

Core Insights - The article discusses the historical evolution and commercialization of soy milk in Hong Kong, highlighting its nutritional value and cultural significance, particularly during the 1930s and 1940s [1][2][3][4][6][7]. Group 1: Historical Context - Soy milk was industrialized in the 1930s, driven by the need to improve the health of the Chinese population during the Japanese invasion [2][3]. - The founder of Vitasoy, Lo Kwai Cheung, recognized the nutritional benefits of soy milk, which is rich in protein, vitamins, and minerals, and aimed to provide affordable nutrition to the impoverished [2][3][6]. Group 2: Marketing Strategies - Lo Kwai Cheung positioned Vitasoy as a modern dairy product, rebranding it from traditional soy milk to a vitamin-rich beverage, packaged in glass bottles to appeal to consumers [3][4]. - The marketing strategy included adopting delivery methods similar to those of dairy companies and opening a tea restaurant to promote Vitasoy alongside traditional Chinese desserts [3][4][6]. Group 3: Cultural Perception - Initially, soy milk was perceived as a "poor man's food" with low nutritional value, and its consumption was limited due to cultural beliefs about its "cold" nature [2][4][5]. - Despite early challenges in sales, Vitasoy eventually gained popularity among younger consumers in the 1970s, aided by changes in production technology and marketing approaches [6][7]. Group 4: Societal Impact - The success of Vitasoy in the 1970s was linked to the emergence of a new middle class in Hong Kong, which embraced modern lifestyles and international food culture [7]. - Vitasoy became a symbol of modern identity and social status, moving beyond its initial role as a nutritional supplement for the underprivileged [6][7].

Performance Summary - Ningde Times (03750.HK) reported a revenue of 178.886 billion yuan for the first half of the year, an increase of 7.27% year-on-year, with a net profit of 30.512 billion yuan, up 33.02% year-on-year [2] - Hisense Home Appliances (00921.HK) achieved a total operating revenue of 49.34 billion yuan, a year-on-year increase of 1.44%, and a net profit of 2.077 billion yuan, up 3.01% year-on-year [2] - New Oriental-S (09901.HK) recorded a net revenue of 4.9 billion USD for the fiscal year 2025, a year-on-year increase of 13.6%, with a net profit of 372 million USD, up 20.1% year-on-year [2] - Weisheng Holdings (03393.HK) reported an operating income of 1.368 billion yuan, a year-on-year increase of 11.88%, and a net profit of 305 million yuan, up 12.24% year-on-year [2] - Yingda Real Estate (00432.HK) had a total revenue of 736 million HKD, a year-on-year growth of 35%, but reported a net loss of approximately 249 million HKD, an increase of 62.75% year-on-year [2] - Saint Bella (02508.HK) announced a profit alert, expecting a net profit of over 320 million yuan, turning from loss to profit year-on-year [2] - Aoneng Construction (01183.HK) issued a profit alert, expecting a net profit increase of over 125% to no less than 18 million MOP year-on-year [2] - Da Cheng Corn Group (03889.HK) issued a profit warning, expecting a net loss of approximately 65 to 85 million HKD, turning from profit to loss year-on-year [2] Company News - Sinopec Oilfield Services (01033.HK) announced that its subsidiary won a natural gas pipeline engineering project with a bid amount of 3.597 billion yuan, accounting for 4.44% of the 2024 revenue [2] - CSPC Pharmaceutical Group (01093.HK) signed an exclusive licensing agreement with MADRIGAL for SYH2086, with potential total payments of up to 2.075 billion USD [2] - China Biopharmaceutical (01177.HK) reported successful external licensing cooperation for LM-299, with a milestone payment of 300 million USD expected to be received soon [2] - Chunquan Industrial Trust (01426.HK) reported an average rental rate of approximately 86% for Huamao Property in the second quarter [2] - Sihuan Pharmaceutical (00460.HK) completed the first patient enrollment in a Phase III clinical trial for the new indication of the innovative drug Annelazole Sodium for gastroesophageal reflux disease [2] - Zhaoke Ophthalmology-B (06622.HK) received orphan drug designation from the FDA for Mephalan for the treatment of retinoblastoma in children [2] - Yunnan Construction Investment Concrete (01847.HK) continues to sign concrete supply contracts for the expansion project of Kunming Changshui International Airport, with a contract amount of approximately 283 million yuan [2] Buyback and Increase Dynamics - Vitasoy International (00345.HK) repurchased 2.122 million shares for approximately 19.6 million HKD at a price range of 9.2 to 9.26 HKD [2] - China Eastern Airlines (00670.HK) spent approximately 7.2536 million HKD to repurchase 2.5 million shares at a price range of 2.89 to 2.92 HKD [2]

证券时报·数据宝统计，VITASOYINT'L在港交所公告显示，7月30日以每股9.200港元至9.260港元的价 格回购212.20万股，回购金额达1959.97万港元。该股当日收盘价9.240港元，下跌0.54%，全天成交额 4901.63万港元。 自7月29日以来公司已连续2日进行回购，合计回购332.40万股，累计回购金额3072.57万港元。 其间该 股累计下跌0.75%。 今年以来该股累计进行28次回购，合计回购1938.00万股，累计回购金额1.82亿港元。（数据宝） VITASOY INT'L回购明细 | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.07.30 | 212.20 | 9.260 | 9.200 | 1959.97 | | 2025.07.29 | 120.20 | 9.260 | 9.240 | 1112.61 | | 2025.07.23 | 140.20 | 9.260 | 9.230 | 1297.92 | | 2025.07.22 | ...